Picture of Compumedics logo

CMP Compumedics Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Momentum

Relative Strength (%)
1m-4.98%
3m-20.22%
6m+25.73%
1yr-29.4%
Volume Change (%)
10d/3m+32.18%
Price vs... (%)
52w High-48.31%
50d MA-5.93%
200d MA-14.58%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value1.73
Price to Tang. Book2.38
Price to Free Cashflow134.93
Price to Sales1.08
EV to EBITDA12.75

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital7.96%
Return on Equity5.93%
Operating Margin5.1%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202330th Jun 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Compumedics EPS forecast chart

Profile Summary

Compumedics Limited (CMP) is a medical device company engaged in the development, manufacture and commercialization of diagnostics technology for the sleep, brain and ultrasonic blood-flow monitoring applications. Its geographic segments include Americas, Australia and Asia Pacific, and Europe and the Middle East. CMP sells it’s a range of products, including sleep diagnostic systems, clinical EEG systems, brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. CMP’s products include Somfit/Somfit Pro, Grael 4K PSG:EEG, Grael PSG, Somte PSG, Somte, Okti and Siesta 802. CMP’s solution for the neurology laboratory from clinical epilepsy monitoring applications to electromyography diagnostics and transcranial doppler sonography. CMP offers brain research technologies through the Compumedics Neuroscan brand. Compumedics Neuroscan technologies provides solutions for electroencephalogram, ERPs, source localization and functional neuro-imaging.

Directors

Last Annual
June 30th, 2022
Last Interim
June 30th, 2022
Incorporated
September 30th, 1987
Public Since
December 21st, 2000
No. of Shareholders
1,967
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
177,162,948

CMP Share Price Performance

Upcoming Events for CMP

Half Year 2023 Compumedics Ltd Earnings Release

Similar to CMP

Picture of 4DMedical logo

4DMedical

au flag iconAustralian Stock Exchange - SEATS

Picture of Adherium logo

Adherium

au flag iconAustralian Stock Exchange - SEATS

Picture of Allegra Orthopaedics logo

Allegra Orthopaedics

au flag iconAustralian Stock Exchange - SEATS

Picture of Analytica logo

Analytica

au flag iconAustralian Stock Exchange - SEATS

Picture of Ansell logo

Ansell

au flag iconAustralian Stock Exchange - SEATS

FAQ

Or unlock with your email

Or unlock with your email